NCT03531216

Brief Summary

The objectives of this prospective crossover, open-label, nonrandomized study are to estimate effect sizes of vasodilatation and sense of warmth after application of topical rosemary essential oil in patients suffering from systemic sclerosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 2, 2015

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 21, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 21, 2016

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

May 9, 2018

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 21, 2018

Completed
Last Updated

January 10, 2019

Status Verified

May 1, 2018

Enrollment Period

5 months

First QC Date

May 9, 2018

Last Update Submit

January 8, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in temperature at the fingers

    Distal skin temperature in °C measured at the fingers with a high-definition infrared camera (FLIR-Systems, type SC660) before and 45 minutes following the oil application

    baseline and 45 minutes after the intervention

Secondary Outcomes (5)

  • Change from baseline in temperature at the back of the hands

    baseline and 45 minutes after the intervention

  • Change from baseline in temperature at the forearms

    baseline and 45 minutes after the intervention

  • Change from baseline of "Herdecke warmth perception questionnaire" (HeWEF)

    baseline and 45 minutes after the intervention

  • "Scleroderma Health Assessment Questionnaire" (SHAQ)

    baseline

  • Rodnan skin score of the hands

    baseline

Study Arms (2)

Topical application of rosemary oil

ACTIVE COMPARATOR

Rosemary essential oil (10% )

Other: Rosemary essential oil

Placebo

PLACEBO COMPARATOR

Pharmaceutical quality olive oil

Other: Placebo

Interventions

Topically-applied oil to both dorsal and palmar aspects of the hands

Topical application of rosemary oil
PlaceboOTHER

Topically-applied oil to both dorsal and palmar aspects of the hands

Placebo

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Systemic sclerosis with skin involvement of hands and fingers
  • Raynaud phenomenon with frequent symptoms of cold hands

You may not qualify if:

  • Topical treatment with nitroglyceride
  • Lymphdrainage \< 24 hours
  • Other topical treatment of hands and arms \< 4 hours prior to study intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

ARCIM Institute

Filderstadt, Baden-Wurttemberg, 70794, Germany

Location

Universitätsklinikum Tuebingen, Abteilung Innere Medizin II

Tübingen, Baden-Wurttemberg, 72076, Germany

Location

MeSH Terms

Conditions

Scleroderma, Systemic

Condition Hierarchy (Ancestors)

Connective Tissue DiseasesSkin and Connective Tissue DiseasesSkin Diseases

Study Officials

  • Jan Vagedes, Dr.

    ARCIM Institute; University of Tuebingen

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 9, 2018

First Posted

May 21, 2018

Study Start

November 2, 2015

Primary Completion

March 21, 2016

Study Completion

March 21, 2016

Last Updated

January 10, 2019

Record last verified: 2018-05

Locations